These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 25766861
1. Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort. Pacheco YM, Jarrin I, Rosado I, Campins AA, Berenguer J, Iribarren JA, Rivero M, Muñoz-Medina L, Bernal-Morell E, Gutiérrez F, Leal M, CoRIS. Antiviral Res; 2015 May; 117():69-74. PubMed ID: 25766861 [Abstract] [Full Text] [Related]
3. Risk of non-AIDS-defining events among HIV-infected patients not yet on antiretroviral therapy. Zhang S, van Sighem A, Kesselring A, Gras L, Prins JM, Hassink E, Kauffmann R, Richter C, de Wolf F, Reiss P, ATHENA national observational HIV cohort study. HIV Med; 2015 May; 16(5):265-72. PubMed ID: 25604160 [Abstract] [Full Text] [Related]
6. Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US. Antiretroviral Therapy Cohort Collaboration (ART-CC). Antivir Ther; 2015 May; 20(1):21-8. PubMed ID: 24675571 [Abstract] [Full Text] [Related]
9. Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease. Borges ÁH, Lundgren JD, Ridolfo A, Katlama C, Antunes F, Grzeszczuk A, Blaxhult A, Mitsura VM, Doroana M, Battegay M, Gargalianos P, Mocroft A, EuroSIDA in EuroCOORD. AIDS; 2014 Nov 13; 28(17):2565-71. PubMed ID: 25574959 [Abstract] [Full Text] [Related]
10. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Guiguet M, Boué F, Cadranel J, Lang JM, Rosenthal E, Costagliola D, Clinical Epidemiology Group of the FHDH-ANRS CO4 cohort. Lancet Oncol; 2009 Dec 13; 10(12):1152-9. PubMed ID: 19818686 [Abstract] [Full Text] [Related]
11. Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition. Cingolani A, Cozzi Lepri A, Castagna A, Goletti D, De Luca A, Scarpellini P, Fanti I, Antinori A, d'Arminio Monforte A, Girardi E. Clin Infect Dis; 2012 Mar 13; 54(6):853-61. PubMed ID: 22157323 [Abstract] [Full Text] [Related]
13. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida. Enferm Infecc Microbiol Clin; 2012 Jun 13; 30(6):e1-89. PubMed ID: 22633764 [Abstract] [Full Text] [Related]
14. Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort. van Lelyveld SF, Gras L, Kesselring A, Zhang S, De Wolf F, Wensing AM, Hoepelman AI, ATHENA national observational cohort study. AIDS; 2012 Feb 20; 26(4):465-74. PubMed ID: 22112603 [Abstract] [Full Text] [Related]
17. Risk for Non-AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy : A Multinational Prospective Cohort Study. Chammartin F, Lodi S, Logan R, Ryom L, Mocroft A, Kirk O, d'Arminio Monforte A, Reiss P, Phillips A, El-Sadr W, Hatleberg CI, Pradier C, Bonnet F, Law M, De Wit S, Sabin C, Lundgren JD, Bucher HC, D:A:D Study Group. Ann Intern Med; 2021 Jun 20; 174(6):768-776. PubMed ID: 33721519 [Abstract] [Full Text] [Related]